A Plasma-based Apolipoprotein and p-tau Elisa Assay to detect Alzheimer’s and differentiate from other dementia types for the NHS (ISSN 2753-8176 (online))
A Plasma-based Apolipoprotein and p-tau Elisa Assay to detect Alzheimer’s and differentiate from other dementia types for the NHS (ISSN 2753-8176 (online)) 1. Ana Pedro 1.Gwyntwr1386 Pharmacy, Regus Chester Business Park, Heronsway, Chester, CH49QR, UK. info@gwyntwr1386.com A - Please select the innovation sector In-vitro diagnostic B- Please provide a brief description of the innovation including relevant disease area(s) and target patient and service user population(s) Apolipoproteins are “any of various proteins that combine with a lipid to form a lipoprotein, such as HDL and LDL”, or “The protein components of lipoproteins, which remain after the lipids to which the proteins are bound have been removed”(1). Apolipoproteins are reported to be linked to many neurodegenerative disorders. APOE plays a role in many brain disorders, including Alzheimer’s disease, mild cognitive impairment, multiple sclerosis, traumatic brain injury, and maybe in more some others ...